Level Chart

Basic Info

Pfizer Inc (PFE) - Rare Disease Revenue is at a current level of 0.000, unchanged from 0.000 last quarter and down from 963.00M one year ago. This is a change of N/A from last quarter and -100.0% from one year ago.

Pfizer Inc Rare Disease Revenue represents the revenue generated by the company from the sale of pharmaceutical products and therapies within the Rare Disease segment

Region United States
Source FinChat.io

Data provided via FinChat.io

Stats

Last Value 0.00
Latest Period Jul 2023
Last Updated Oct 5 2023, 11:15 EDT
Average Growth Rate -25.01%
Value from Last Quarter 0.00
Change from Last Quarter N/A
Value from 1 Year Ago 963.00M
Change from 1 Year Ago -100.0%
Frequency Quarterly
Unit USD
Adjustment N/A

Historical Data

View and export this data back to 2019. Upgrade now.
Date Value
July 02, 2023 0.00
March 31, 2023 0.00
December 31, 2022 0.00
October 02, 2022 0.00
July 03, 2022 909.00M
April 03, 2022 963.00M
December 31, 2021 950.00M
October 03, 2021 869.00M
Date Value
July 04, 2021 895.00M
April 04, 2021 824.00M
December 31, 2020 865.00M
September 27, 2020 752.00M
June 28, 2020 681.00M
March 29, 2020 639.00M
December 31, 2019 686.00M

Basic Info

Pfizer Inc (PFE) - Rare Disease Revenue is at a current level of 0.000, unchanged from 0.000 last quarter and down from 963.00M one year ago. This is a change of N/A from last quarter and -100.0% from one year ago.

Pfizer Inc Rare Disease Revenue represents the revenue generated by the company from the sale of pharmaceutical products and therapies within the Rare Disease segment

Region United States
Source FinChat.io

Data provided via FinChat.io

Stats

Last Value 0.00
Latest Period Jul 2023
Last Updated Oct 5 2023, 11:15 EDT
Average Growth Rate -25.01%
Value from Last Quarter 0.00
Change from Last Quarter N/A
Value from 1 Year Ago 963.00M
Change from 1 Year Ago -100.0%
Frequency Quarterly
Unit USD
Adjustment N/A

Related Securities

Symbol Name Change %
PFE Pfizer Inc 0.30%